Poor metabolizers (~5-10% of people) clear BPC-157 more slowly, meaning the standard dose produces higher tissue levels they may need to start lower (200-250 mcg)
Clinical trials have shown that GLP-1 medications can help patients lose weight and better control blood sugar, potentially reducing the risk of heart attacks, strokes and other serious health complications
Summary Table Disclaimer For Research Use Only
Events, Partnerships & Group IV Services We provide professionally managed mobile IV services across Northern California for executive retreats, conferences, brand activations, weddings, athletic events, gyms, wellness studios, hotels, concierge teams, and lifestyle brands seeking highly personalized, professional IV care